In aggressive breast cancers, the expression levels of positive regulators of SERPINB2, such as FOXL2 (Z-score = 2.863, p-value = 0.258) and ERK (Z-score = 3.346, p-value = 0.677), were activated (Figure 5D). This evidence concerns the gene FOXL2 and breast cancer.